Regulus Therapeutics Performance

Regulus Therapeutics Relative Risk vs. Return Landscape

If you would invest  816.00  in Regulus Therapeutics on November 13, 2025 and sell it today you would earn a total of  0.00  from holding Regulus Therapeutics or generate 0.0% return on investment over 90 days. Regulus Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Regulus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.

Regulus Therapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Regulus Therapeutics has a beta of -4.0 indicating as returns on its benchmark rise, returns on holding Regulus Therapeutics are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Regulus Therapeutics is expected to outperform its benchmark. In addition to that Regulus Therapeutics has an alpha of 3.9585, implying that it can generate a 3.96 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Regulus Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Regulus Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 8.16 8.16 8.16 Details

Intrinsic Valuation Low Real High 5.57 5.57 8.98 Details

Regulus Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Regulus Therapeutics is not an exception. The market had few large corrections towards the Regulus Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Regulus Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Regulus Therapeutics within the framework of very fundamental risk indicators.

Regulus Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Regulus Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Regulus Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Regulus Therapeutics Price Density Drivers

Regulus Therapeutics Fundamentals Growth

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

If you are still planning to invest in Regulus Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regulus Therapeutics' history and understand the potential risks before investing.